Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:48 PM
Study NCT ID:
NCT04975451
Status:
UNKNOWN
Last Update Posted:
2021-07-27
First Post:
2021-07-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer
Sponsor:
Anqin Zhang
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-14
First Submit QC Date:
None
Study First Post Date:
2021-07-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-26
Last Update Post Date:
2021-07-27
Last Update Post Date Type:
ACTUAL